Has Leonard Kibuule, MD received payments from drug or device companies?

Yes. Drug and device makers reported $621,134 in general payments to Leonard Kibuule, MD across 821 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Leonard Kibuule, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Leonard Kibuule, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Leonard Kibuule, MD

Orthopaedic Surgery of the Spine · Houston, TXNPI 1962629543

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $396,338 of the $621,134 with a category attached, or 63.8%. Medtronic accounts for 93.9% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2019 at $192,429 and has fallen 98.2% since, to $3,516 in 2025. Among orthopaedic surgery of the spine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$621,134in general payments, 2019–2025

Across 821 payments — averaging $756.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$584K
Globus Medical$19K
Relievant Medsystems, Inc.$13K
Stryker$1K
Johnson & Johnson$992
Nexxt Spine LLC$530
plus $3K from 21 others

$47,375in research payments, 2019–2025

Across 2 payments — averaging $23,688 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$47K

What the payments were for

Consulting fees$147,12324%
Speaking & faculty fees$396,33864%
Travel & lodging$52,6588%
Food & beverage$25,0154%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	658	$583,521
Globus Medical(2 entities)	63	$19,211
Relievant Medsystems, Inc.	19	$13,110
Stryker	17	$1,201
Johnson & Johnson(2 entities)	16	$992
Nexxt Spine LLC	3	$530
Xtant Medical Inc	3	$323
Nevro Corp.	6	$312
Cerapedics Inc.	2	$294
Alphatec Spine, Inc	2	$228
Novapproach Spine, LLC	3	$191
Si-bone, Inc.	2	$188
Osteocentric Technologies, Inc.	1	$148
Bioventus LLC	4	$136
Orthofix Medical, Inc.	1	$132
Zimmer Biomet	1	$105
Abbott	4	$83
Saluda Medical Americas, Inc.	2	$79
Boston Scientific	4	$75
Zavation Medical Products, LLC	1	$61
Spinal Elements, Inc.	1	$48
Scilex Pharmaceuticals Inc.	2	$37
Vericel Corporation	2	$35
Biocomposites Inc	1	$31
Viseon, Inc.	1	$28
Biotronik NRO, Inc.	1	$22
Arteriocyte Medical Systems, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

PIVOX Oblique Lateral Spinal System$161,707
MAZOR X SYSTEM$88,764
O-ARM-ST$57,978
CD HORIZON$43,712
CD HORIZON SPINAL SYSTEM$41,532
DIVERGENCE-L$35,545
CLYDESDALE$33,448
MazorX - Renaissance$25,309
Intracept$25,190
KYPHON Balloon Kyphoplasty$11,994
Mazor X Stealth Edition$11,993
KYPHON EXPRESS II KYPHOPAK TRAY$7,502
StealthStation$6,965
O-ARM$6,584
AQUAMANTYS$5,531
Pulse$5,423
TLIF$3,875
O-ARM-Spine$2,387
CLYDESDALE PTC SPINAL SYSTEM$1,649
XLIF$1,423

How this compares

$621,134 in reported general payments places this provider in the 90th percentile of 207 orthopaedic surgery of the spine providers in Texas.

See all orthopaedic surgery of the spine providers in Texas →

Medicare billing

Part B allowed, 2024

$41,676

Medicare patients

Services billed

151

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	17	$247
Methylprednisolone	36	$192
Tramadol Hcl	21	$66

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Houston

David WimberleyHouston$2.2M
Shah-Nawaz DodwadHouston$710K
Vivek KushwahaHouston$573K
Robert MohrHouston$352K
Bernhard MeyerHouston$238K
Ryan StuckeyHouston$181K
Rex MarcoHouston$174K
Richard FrancisHouston$156K
Ra'kerry RahmanHouston$45K
Randall DryerAustin$2.9M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →